• Lung Cancer Edition: Top Headlines for Week of July 15, 2024

  • Jul 18 2024
  • Length: 13 mins
  • Podcast

Lung Cancer Edition: Top Headlines for Week of July 15, 2024

Listen for free

View show details

  • Summary

  • In this edition, atezolizumab benefits PD-L1-selected patients with NSCLC, risks persist with e-cigarette use after quitting tobacco smoking and more.

    Read the full coverage here:

    Adjuvant atezolizumab benefits PD-L1-selected patients with NSCLC

    Lung cancer risks persist with e-cigarette use after quitting tobacco smoking

    COPD, IPF end of life health care use differs from lung cancer

    Tecentriq combination fails to improve survival in metastatic lung cancer

    Risk for lung cancer reoccurrence may be associated with OSA-related hypoxemia

    References:

    Figueroa Rodriguez F, et al. 0468: CRASH: Cancer reoccurrence is accelerated by episodic hypoxemia. Presented at: SLEEP; June 1-5, 2024; Houston.

    Kim Y, et al. Association of electronic cigarette use after conventional smoking cessation with lung cancer risk: A nationwide cohort study. Presented at: American Thoracic Society International Conference; May 18-22, 2024; San Diego.

    Press Release

    Suen AO, et al. Am J Respir Crit Care Med. 2024;doi:10.1154/ajrccm-conference.2024.209.1_MeetingAbstracts.A5040.

    Wakelee HA, et al. Abstract LBA8035. Presented at: ASCO Annual Meeting; May 31-June 4, 2024; Chicago.
    Show more Show less
Show more Show less

What listeners say about Lung Cancer Edition: Top Headlines for Week of July 15, 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available